Imaging 2020 VI: Imaging Biopathways
September 13-17, 2009
Jackson Hole, Wyoming
Future medical therapies will increasingly focus on interrupting and redirecting pathologic biopathways at the genetic and cellular level. Imaging – especially molecular imaging - will play an indispensible role in the understanding of biopathways, the creation of biospecific interventions, and the monitoring and control of new, highly potent interventions.
Future imaging will require significantly greater sensitivity, specificity and quantitative robustness than exists today. The most significant evolution and greatest challenge will be increasing the specificity. To fully integrate imaging into therapeutics and diagnosis, imaging will need to be applicable to screening and interrogating therapeutically useful biopathways. Sessions have been designed around these themes. Discussions will address future advances in engineering and imaging modalities from NIR to X ray, microscopic in vivo imaging, fundamental advances in important biopathways (angiogenesis, metastasis, invasion and resistance, neurodegeneration, et al.), and the future roles of chemistry in imaging.
Key to meeting the challenges inherent in a complex future is open and effective communication among basic and clinical researchers from a wide spectrum of relevant disciplines. The goal of Imaging in 2020 is to catalyze this communication by laying the technical foundation for it, and by providing a format that is intentionally less structured than the traditional scientific meeting, allowing for extensive, meaningful interactions in a casual, comfortable environment. We hope to foster the development of enduring associations that will lead to innovative solutions and applications.
Imaging in 2020 VI will be held at the Jackson Lake Lodge in Jackson Hole, Wyoming. Its beautiful location in Grand Teton National Forest is easily accessible from Jackson Airport. Breathtaking views of the Grand Tetons provide a colorful backdrop to the meeting. Participants will have the opportunity during the unscheduled afternoons to enjoy a variety of outdoor activities, such as hiking, fishing, boating, horseback riding, or just relaxing in a truly spectacular natural setting.
| Sunday, September 13 | ||
| 4:00 - 6:00 pm | Registration and Poster Set-up | |
| 6:00 - 7:00 pm | Dinner | |
| 7:00 - 7:15 pm | Welcome | Mike Tweedle |
| 7:15 - 9:00 pm | Session I: Engineering | |
| 7:15 - 7:30 pm | Session Remarks (1999) | Tom Budinger (Moderator) |
| 7:30 - 8:15 pm | Hardware, Miniaturization, Microfluidics | Greg Auner |
| 8:15 - 9:00 pm | The Future of Today's Modalities | John Gore |
| 9:00 - 10:00 pm | Reception and Poster Session | |
| Monday, September 14 | ||
| 7:00 - 8:00 am | Breakfast | |
| 8:00 - 9:45 am | Session II: Chemistry I | |
| 8:00 - 8:15 am | Session Remarks (1999) | Mike Tweedle (Moderator) |
| 8:15 - 9:00 am | Supramolecular Chemistry | Akira Harada |
| 9:00 - 9:45 am | Multimodality Imaging Agents | Angelique Louie |
| 9:45 - 10:00 am | Break | |
| 10:00 - 12:15 pm | Session III: Biopathways I | |
| 10:00 - 10:45 am | Session Remarks/Angiogenesis Pathology | Don McDonald |
| 10:45 - 11:30 am | MRI Angiogenesis | Michal Neeman |
| 11:30 - 12:15 pm | PET Angiogenesis | Markus Schwaiger |
| 12:15 - 1:15 pm | Lunch | |
| 1:15 - 6:00 pm | Afternoon free time | |
| 6:00 - 7:00 pm | Dinner | |
| 7:15 - 8:45 pm | Session IV: Biopathways II | |
| 7:00 - 7:15 pm | Session Remarks (2003) | Adrian Nunn (Moderator) |
| 7:15 - 8:00 pm | Metatases & Cell Motility | John Condeelis |
| 8:00 - 8:45 pm | Cancer Invasion and Resistance | Peter Friedl |
| 8:45 - 10:00 pm | Reception and Poster Session | |
| Tuesday, September 15 | ||
| 7:00 - 8:00 am | Breakfast | |
| 8:00 - 9:45 am | Session V: Chemistry II | |
| 8:00 - 8:15 am | Session Remarks (1999) | Tom Meade (Moderator) |
| 8:15 - 9:00 am | Topic TBD | Brian Hoffman |
| 9:00 - 9:45 am | Topic TBD | Ken Raymond |
| 9:45 - 10:15 am | Group Photo, Break | |
| 10:15 - 12:00 pm | Session VI: Pharmaceuticals | |
| 10:15 - 10:30 am | Session Remarks | Bradford Navia (Moderator) |
| 10:30 - 11:15 am | Neurodegenerative Disease | Dan Silverman |
| 11:15 - 12:00 pm | Imaging Biomarkers in Cancer | Michael Smith |
| 12:00 - 12:45 pm | Lunch | |
| 12:45 - 6:00 pm | Afternoon free time/Bus trip into Jackson Hole | |
| 6:00 - 6:45 pm | Reception | |
| 6:45 - 7:45 pm | Dinner | |
| 7:45 - 7:55 pm | Introduction of Keynote Speaker | Bonnie Sloane |
| 7:55 - 8:55 pm | Keynote Address | Roger Tsien 2008 Nobel Prizewinner for Chemistry |
| Wednesday, September 16 | ||
| 7:00 - 8:00 am | Breakfast | |
| 8:00 - 9:45 am | Sessoin VII: Ultrasound Agents | |
| 8:00 - 8:15 am | Session Remarks (1999) | Kathy Ferrara (Moderator) |
| 8:15 - 9:00 am | Targeted Ultrasound Agents | Sasha Klibanov |
| 9:00 - 9:45 am | Advances in Technology for Ultrasound Contrast Imaging | Paul Dayton |
| 9:45 - 10:00 am | Break | |
| 10:00 - 11:45 am | Session VIII: Microscopy | |
| 10:00 - 10:15 am | Session Remarks | Bob Gillies (Moderator) |
| 10:15 - 11:00 am | Endoscopic Microscopy | Rebecca Richards-Kortum |
| 11:00 - 11:45 am | Microscopy with Gallium Ions | Sriram Subramaniam |
| 11:45 - 12:30 pm | Lunch | |
| 12:45 - 6:00 pm | Afternoon free time | |
| 6:00 - 7:00 pm | Dinner | |
| 7:00 - 8:45 pm | Session IX: Animal Models | |
| 7:00 - 7:15 pm | Session Remarks (1999) | Dan Sullivan (Moderator) |
| 7:15 - 8:00 pm | Animal Model Development | Terry Van Dyke |
| 8:00 - 8:45 pm | Animal Models for Optical Imaging | David Kirsch |
| 8:45 - 10:00 pm | Reception and Poster Session | |
| Thursday, September 17 | ||
| 7:00 - 8:00 am | Breakfast | |
| 8:00 - 10:15 am | Session X: Imaging Biologicals | |
| 8:00 - 8:15 am | Session Remarks | Sarah Nelson (Moderator) |
| 8:15 - 9:00 am | Cell Imaging In Vivo | Joe Frank |
| 9:00 - 9:45 am | Imaging Enzymes | Matthew Bogyo |
| 9:45 - 10:15 am | Meeting Summary & Concluding Remarks | Bonnie Sloane, Mike Tweedle |
